Dyadic international, inc. and proliant health and biologicals announce recombinant albumin development and commercialization partnership

Jupiter, fla., june 28, 2024 (globe newswire) -- dyadic international, inc. (“dyadic”) (nasdaq: dyai), announced today that they have entered into a development and commercialization partnership with proliant health and biologicals (phb), a leading supplier of purified proteins for the diagnostic, nutrition and cell culture markets.
DYAI Ratings Summary
DYAI Quant Ranking